Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Ischaemia-free liver transplantation in humans: a first-in-human trial

Zhiyong Guo,Qiang Zhao,Shanzhou Huang,Changjun Huang,Dongping Wang,Lu Yang,Jian Zhang,Maogen Chen,Linwei Wu,Zhiheng Zhang,Zebin Zhu,Linhe Wang,Caihui Zhu,Yixi Zhang,Yunhua Tang,Chengjun Sun,Wei Xiong,Yuekun Shen,Xiaoxiang Chen,Jinghong Xu,Tielong Wang,Yi Ma,Anbin Hu,Yinghua Chen,Xiaofeng Zhu,Jian Rong,Changjie Cai,Fengqiu Gong,Xiangdong Guan,Wenqi Huang,Dicken Shiu-Chung Ko,Xianchang Li,Stefan G Tullius,Jiefu Huang,Weiqiang Ju,Xiaoshun He

The Lancet Regional Health - Western Pacific（2021）

Cited 19|Views56
No score
Abstract
Background Ischaemia-reperfusion injury is considered an inevitable component of organ transplantation, compromising organ quality and outcomes. Although several treatments have been proposed, none has avoided graft ischaemia and its detrimental consequences.
More
Translated text
Key words
liver transplantation,ischaemia-free,first-in-human
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined